| Income Statement | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Net sales | 363,893 | - | 309,261 | 260,432 |
| Cost of goods sold | 244,110 | - | 207,391 | 176,937 |
| Gross profit | 119,783 | 0 | 101,870 | 83,495 |
| Selling, general and administrative expenses | 68,523 | - | 76,337 | 65,796 |
| Operating income | 51,260 | 0 | 25,533 | 17,699 |
| Interest expense, net | -12,059 | - | -8,996 | -7,641 |
| Foreign currency losses, net | -2,934 | - | -11,699 | -438 |
| Income before income taxes | 36,267 | - | 4,838 | 9,620 |
| Provision for income taxes | 9,740 | - | 1,653 | 2,645 |
| Net income | 26,527 | - | 3,185 | 6,975 |
| Earnings per share, basic | 0.65 | 0.52 | 0.08 | 0.17 |
| Earnings per share, diluted | 0.65 | 0.51 | 0.08 | 0.17 |
| Weighted average number of shares outstanding, basic | 40,534,000 | 40,520,000 | 40,504,000 | 40,504,000 |
| Weighted average number of shares outstanding, diluted | 40,877,000 | 40,709,000 | 40,715,000 | 40,582,000 |
PHIBRO ANIMAL HEALTH CORP (PAHC)
PHIBRO ANIMAL HEALTH CORP (PAHC)